SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-199383
Filing Date
2013-05-03
Accepted
2013-05-03 17:01:37
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d497063d10q.htm 10-Q 609931
2 EX-31.1 d497063dex311.htm EX-31.1 10791
3 EX-31.2 d497063dex312.htm EX-31.2 10792
4 EX-32.1 d497063dex321.htm EX-32.1 5942
  Complete submission text file 0001193125-13-199383.txt   4691083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20130331.xml EX-101.INS 567961
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20130331.xsd EX-101.SCH 60816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20130331_cal.xml EX-101.CAL 41256
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20130331_def.xml EX-101.DEF 287810
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20130331_lab.xml EX-101.LAB 431587
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20130331_pre.xml EX-101.PRE 336290
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 13813493
SIC: 2834 Pharmaceutical Preparations